Non-classic forms of atherogenic dyslipidemia in women with polycystic ovary syndrome.
Márcia dos Santos Rizzo, G.B. Rini, Enrico Carmina(OHB (Italy)), Ilenia Pepe(University of Palermo), Martin Hersberger(University Children's Hospital Zurich), Giatgen A. Spinas(Core Laboratories (United States)), Gaetana Di Fede(University of Palermo), Kaspar Berneis
Nova Science Publishers (Nova Science Publishers, Inc.)
January 1, 2008
Cited by 0
Related Papers
Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group
|Fertility and Sterility|2011|2k
Polycystic ovary syndrome
|Nature Reviews Disease Primers|2016|1.9k
American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society Disease State Clinical Review: Guide to the Best Practices in the Evaluation and Treatment of Polycystic Ovary Syndrome - Part 1
|Endocrine Practice|2015|628
Polycystic Ovary Syndrome (PCOS): Arguably the Most Common Endocrinopathy Is Associated with Significant Morbidity in Women
|The Journal of Clinical Endocrinology & Metabolism|1999|508
Lipid levels in polycystic ovary syndrome: systematic review and meta-analysis
|Fertility and Sterility|2011|469